{"entity":{"type":"insider","cik":"0001748212","url":"/insider/0001748212","json_url":"/insider/0001748212.json","name":"SkyKnight Capital Fund II, L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":19,"n_filings":10,"first":"2022-03-08","last":"2023-08-14","span_basis":"filed_date"},"name_variants":[{"name":"SkyKnight Capital Fund II, L.P.","source":"filing","n_filings":10,"first_seen":"2022-03-08","last_seen":"2023-08-14"}],"transactions":[{"id":8108450,"accession":"0000950170-23-042448","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-23-042448","line_url":"/filing/0000950170-23-042448","is_derivative":false,"issuer_cik":"0001725255","issuer_name":"AdaptHealth Corp.","issuer_ticker":"AHCO","issuer_name_source":null,"issuer_url":"/issuer/0001725255","owner_cik":null,"owner_name":"Ebbel Matthew; SkyKnight Aero Holdings, LLC; SkyKnight Capital Fund II, L.P.; SkyKnight Capital II GP, LLC; SkyKnight Capital Management, LLC; SkyKnight Capital, L.P.","owner_display_name":"Ebbel Matthew","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":196839.0,"shares_display":"196,839","price_per_share":14.015,"price_display":"14.02","price_state":"stated","total_value":2758698.585,"total_display":"2,758,698.58","total_whole":"2,758,699","shares_owned_after":2815117.0,"shares_owned_after_display":"2,815,117","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-11","filed_date":"2023-08-14","scope":"insider","n_lines":2},{"id":8108441,"accession":"0000950170-23-042448","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-23-042448","line_url":"/filing/0000950170-23-042448","is_derivative":false,"issuer_cik":"0001725255","issuer_name":"AdaptHealth Corp.","issuer_ticker":"AHCO","issuer_name_source":null,"issuer_url":"/issuer/0001725255","owner_cik":null,"owner_name":"Ebbel Matthew; SkyKnight Aero Holdings, LLC; SkyKnight Capital Fund II, L.P.; SkyKnight Capital II GP, LLC; SkyKnight Capital Management, LLC; SkyKnight Capital, L.P.","owner_display_name":"Ebbel Matthew","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":128788.0,"shares_display":"128,788","price_per_share":14.0462,"price_display":"14.05","price_state":"stated","total_value":1808982.0056,"total_display":"1,808,982.01","total_whole":"1,808,982","shares_owned_after":2952904.0,"shares_owned_after_display":"2,952,904","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-10","filed_date":"2023-08-14","scope":"insider","n_lines":2},{"id":6443569,"accession":"0000899243-22-022559","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-022559","line_url":"/filing/0000899243-22-022559#line-1","is_derivative":false,"issuer_cik":"0001725255","issuer_name":"AdaptHealth Corp.","issuer_ticker":"AHCO","issuer_name_source":null,"issuer_url":"/issuer/0001725255","owner_cik":null,"owner_name":"SkyKnight Capital II GP, LLC; SkyKnight Capital Fund II, L.P.; Ebbel Matthew","owner_display_name":"SkyKnight Capital II GP, LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":17.2201,"price_display":"17.22","price_state":"stated","total_value":1722010.0,"total_display":"1,722,010.00","total_whole":"1,722,010","shares_owned_after":3043056.0,"shares_owned_after_display":"3,043,056","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-13","filed_date":"2022-06-15","scope":"insider"},{"id":6714241,"accession":"0000899243-22-022193","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-022193","line_url":"/filing/0000899243-22-022193#line-2","is_derivative":false,"issuer_cik":"0001725255","issuer_name":"AdaptHealth Corp.","issuer_ticker":"AHCO","issuer_name_source":null,"issuer_url":"/issuer/0001725255","owner_cik":null,"owner_name":"Ebbel Matthew; SkyKnight Capital Fund II, L.P.; SkyKnight Capital II GP, LLC","owner_display_name":"Ebbel Matthew","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7923.0,"shares_display":"7,923","price_per_share":17.3906,"price_display":"17.39","price_state":"stated","total_value":137785.7238,"total_display":"137,785.72","total_whole":"137,786","shares_owned_after":2943056.0,"shares_owned_after_display":"2,943,056","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-10","filed_date":"2022-06-13","scope":"insider"},{"id":6714237,"accession":"0000899243-22-022193","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-022193","line_url":"/filing/0000899243-22-022193#line-1","is_derivative":false,"issuer_cik":"0001725255","issuer_name":"AdaptHealth Corp.","issuer_ticker":"AHCO","issuer_name_source":null,"issuer_url":"/issuer/0001725255","owner_cik":null,"owner_name":"Ebbel Matthew; SkyKnight Capital Fund II, L.P.; SkyKnight Capital II GP, LLC","owner_display_name":"Ebbel Matthew","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5999.0,"shares_display":"5,999","price_per_share":17.498,"price_display":"17.50","price_state":"stated","total_value":104970.502,"total_display":"104,970.50","total_whole":"104,971","shares_owned_after":2935133.0,"shares_owned_after_display":"2,935,133","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-09","filed_date":"2022-06-13","scope":"insider"},{"id":6645345,"accession":"0000899243-22-021040","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-021040","line_url":"/filing/0000899243-22-021040#line-1","is_derivative":false,"issuer_cik":"0001725255","issuer_name":"AdaptHealth Corp.","issuer_ticker":"AHCO","issuer_name_source":null,"issuer_url":"/issuer/0001725255","owner_cik":null,"owner_name":"SkyKnight Capital II GP, LLC; SkyKnight Capital Fund II, L.P.; Ebbel Matthew","owner_display_name":"SkyKnight Capital II GP, LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":35091.0,"shares_display":"35,091","price_per_share":17.5686,"price_display":"17.57","price_state":"stated","total_value":616499.7426,"total_display":"616,499.74","total_whole":"616,500","shares_owned_after":2929134.0,"shares_owned_after_display":"2,929,134","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-01","filed_date":"2022-06-03","scope":"insider"},{"id":6471801,"accession":"0000899243-22-019927","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-019927","line_url":"/filing/0000899243-22-019927#line-1","is_derivative":false,"issuer_cik":"0001725255","issuer_name":"AdaptHealth Corp.","issuer_ticker":"AHCO","issuer_name_source":null,"issuer_url":"/issuer/0001725255","owner_cik":null,"owner_name":"SkyKnight Capital II GP, LLC; Ebbel Matthew; SkyKnight Capital Fund II, L.P.","owner_display_name":"SkyKnight Capital II GP, LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":17.5,"price_display":"17.50","price_state":"stated","total_value":3500.0,"total_display":"3,500.00","total_whole":"3,500","shares_owned_after":2894043.0,"shares_owned_after_display":"2,894,043","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-25","filed_date":"2022-05-27","scope":"insider"},{"id":6840951,"accession":"0000899243-22-019372","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-019372","line_url":"/filing/0000899243-22-019372#line-3","is_derivative":false,"issuer_cik":"0001725255","issuer_name":"AdaptHealth Corp.","issuer_ticker":"AHCO","issuer_name_source":null,"issuer_url":"/issuer/0001725255","owner_cik":null,"owner_name":"SkyKnight Capital II GP, LLC; SkyKnight Capital Fund II, L.P.; Ebbel Matthew","owner_display_name":"SkyKnight Capital II GP, LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":17.2723,"price_display":"17.27","price_state":"stated","total_value":1727230.0,"total_display":"1,727,230.00","total_whole":"1,727,230","shares_owned_after":2893843.0,"shares_owned_after_display":"2,893,843","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-24","filed_date":"2022-05-24","scope":"insider"},{"id":6840946,"accession":"0000899243-22-019372","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-019372","line_url":"/filing/0000899243-22-019372#line-2","is_derivative":false,"issuer_cik":"0001725255","issuer_name":"AdaptHealth Corp.","issuer_ticker":"AHCO","issuer_name_source":null,"issuer_url":"/issuer/0001725255","owner_cik":null,"owner_name":"SkyKnight Capital II GP, LLC; SkyKnight Capital Fund II, L.P.; Ebbel Matthew","owner_display_name":"SkyKnight Capital II GP, LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9300.0,"shares_display":"9,300","price_per_share":17.4363,"price_display":"17.44","price_state":"stated","total_value":162157.59,"total_display":"162,157.59","total_whole":"162,158","shares_owned_after":2793843.0,"shares_owned_after_display":"2,793,843","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-23","filed_date":"2022-05-24","scope":"insider"},{"id":6840936,"accession":"0000899243-22-019372","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-019372","line_url":"/filing/0000899243-22-019372#line-1","is_derivative":false,"issuer_cik":"0001725255","issuer_name":"AdaptHealth Corp.","issuer_ticker":"AHCO","issuer_name_source":null,"issuer_url":"/issuer/0001725255","owner_cik":null,"owner_name":"SkyKnight Capital II GP, LLC; SkyKnight Capital Fund II, L.P.; Ebbel Matthew","owner_display_name":"SkyKnight Capital II GP, LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":17.3294,"price_display":"17.33","price_state":"stated","total_value":1732940.0,"total_display":"1,732,940.00","total_whole":"1,732,940","shares_owned_after":2784543.0,"shares_owned_after_display":"2,784,543","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-20","filed_date":"2022-05-24","scope":"insider"},{"id":6318426,"accession":"0000899243-22-018602","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-018602","line_url":"/filing/0000899243-22-018602#line-1","is_derivative":false,"issuer_cik":"0001725255","issuer_name":"AdaptHealth Corp.","issuer_ticker":"AHCO","issuer_name_source":null,"issuer_url":"/issuer/0001725255","owner_cik":null,"owner_name":"SkyKnight Capital Fund II, L.P.; Ebbel Matthew; SkyKnight Capital II GP, LLC","owner_display_name":"SkyKnight Capital Fund II, L.P.","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":21632.0,"shares_display":"21,632","price_per_share":16.2028,"price_display":"16.20","price_state":"stated","total_value":350498.9696,"total_display":"350,498.97","total_whole":"350,499","shares_owned_after":2684543.0,"shares_owned_after_display":"2,684,543","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-16","filed_date":"2022-05-18","scope":"insider"},{"id":6443370,"accession":"0000899243-22-018138","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-018138","line_url":"/filing/0000899243-22-018138#line-3","is_derivative":false,"issuer_cik":"0001725255","issuer_name":"AdaptHealth Corp.","issuer_ticker":"AHCO","issuer_name_source":null,"issuer_url":"/issuer/0001725255","owner_cik":null,"owner_name":"SkyKnight Capital II GP, LLC; SkyKnight Capital Fund II, L.P.; Ebbel Matthew","owner_display_name":"SkyKnight Capital II GP, LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":15.9396,"price_display":"15.94","price_state":"stated","total_value":1593960.0,"total_display":"1,593,960.00","total_whole":"1,593,960","shares_owned_after":2662911.0,"shares_owned_after_display":"2,662,911","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-13","filed_date":"2022-05-16","scope":"insider"},{"id":6443367,"accession":"0000899243-22-018138","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-018138","line_url":"/filing/0000899243-22-018138","is_derivative":false,"issuer_cik":"0001725255","issuer_name":"AdaptHealth Corp.","issuer_ticker":"AHCO","issuer_name_source":null,"issuer_url":"/issuer/0001725255","owner_cik":null,"owner_name":"SkyKnight Capital II GP, LLC; SkyKnight Capital Fund II, L.P.; Ebbel Matthew","owner_display_name":"SkyKnight Capital II GP, LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":80154.0,"shares_display":"80,154","price_per_share":15.160306734536018,"price_display":"15.16","price_state":"stated","total_value":1215159.226,"total_display":"1,215,159.23","total_whole":"1,215,159","shares_owned_after":2562911.0,"shares_owned_after_display":"2,562,911","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-12","filed_date":"2022-05-16","scope":"insider","n_lines":2},{"id":6803202,"accession":"0000899243-22-011073","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-011073","line_url":"/filing/0000899243-22-011073#line-2","is_derivative":false,"issuer_cik":"0001725255","issuer_name":"AdaptHealth Corp.","issuer_ticker":"AHCO","issuer_name_source":null,"issuer_url":"/issuer/0001725255","owner_cik":null,"owner_name":"Ebbel Matthew; SkyKnight Capital Fund II, L.P.; SkyKnight Capital II GP, LLC","owner_display_name":"Ebbel Matthew","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":15.2467,"price_display":"15.25","price_state":"stated","total_value":381167.5,"total_display":"381,167.50","total_whole":"381,168","shares_owned_after":2482757.0,"shares_owned_after_display":"2,482,757","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-14","filed_date":"2022-03-15","scope":"insider"},{"id":6803198,"accession":"0000899243-22-011073","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-011073","line_url":"/filing/0000899243-22-011073#line-1","is_derivative":false,"issuer_cik":"0001725255","issuer_name":"AdaptHealth Corp.","issuer_ticker":"AHCO","issuer_name_source":null,"issuer_url":"/issuer/0001725255","owner_cik":null,"owner_name":"Ebbel Matthew; SkyKnight Capital Fund II, L.P.; SkyKnight Capital II GP, LLC","owner_display_name":"Ebbel Matthew","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":17486.0,"shares_display":"17,486","price_per_share":15.5,"price_display":"15.50","price_state":"stated","total_value":271033.0,"total_display":"271,033.00","total_whole":"271,033","shares_owned_after":2457757.0,"shares_owned_after_display":"2,457,757","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-11","filed_date":"2022-03-15","scope":"insider"},{"id":6235252,"accession":"0000899243-22-009977","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-009977","line_url":"/filing/0000899243-22-009977#line-1","is_derivative":false,"issuer_cik":"0001725255","issuer_name":"AdaptHealth Corp.","issuer_ticker":"AHCO","issuer_name_source":null,"issuer_url":"/issuer/0001725255","owner_cik":null,"owner_name":"SkyKnight Capital II GP, LLC; SkyKnight Capital Fund II, L.P.; Ebbel Matthew","owner_display_name":"SkyKnight Capital II GP, LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":13352.0,"shares_display":"13,352","price_per_share":14.9989,"price_display":"15.00","price_state":"stated","total_value":200265.3128,"total_display":"200,265.31","total_whole":"200,265","shares_owned_after":2440271.0,"shares_owned_after_display":"2,440,271","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-04","filed_date":"2022-03-08","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001725255","name":"AdaptHealth Corp.","url":"/issuer/0001725255","role":"Director","n_filings":10,"first_seen":"2022-03-08","last_seen":"2023-08-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001748212","retrieved_at":"2026-08-24T15:26:33+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}